Dynamic Splinting for Patients With Adhesive Capsulitis (DS-SDH)

This study has been terminated.
(Unrelated to trial)
McMurry University
Information provided by (Responsible Party):
Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier:
First received: March 31, 2009
Last updated: August 8, 2013
Last verified: August 2013
The purpose of this study is to compare two treatments for adhesive capsulitis.

Condition Intervention
Adhesive Capsulitis
Device: Dynasplint

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Outcomes Following Dynamic Splinting and/or Physical Therapy for Patients With Adhesive Capsulitis

Resource links provided by NLM:

Further study details as provided by Dynasplint Systems, Inc.:

Primary Outcome Measures:
  • Number of physical therapy treatments required [ Time Frame: throughout trial ] [ Designated as safety issue: No ]
  • Weeks of Dynasplint treatment [ Time Frame: throughout trial ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Shoulder Range Of Motion [ Time Frame: initial consultation, first visit following injection, and monthly following injection ] [ Designated as safety issue: No ]
  • Sharp FAS Neck and Shoulder [ Time Frame: initial consultation, immediatly prior to first treatment following injection, and monthly following injection ] [ Designated as safety issue: No ]
  • Disabilities of Arm, Hand, and Shoulder Questionnaire [ Time Frame: initial visit, first visit following injection, and weekly until discharge ] [ Designated as safety issue: No ]

Enrollment: 10
Study Start Date: January 2006
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Physical Therapy Group
Patient's in the Physical Therapy Group will have the standard manual treatments during their usual physical therapy visits with no additional intervention
Experimental: Dynasplint Group
Along with standard manual physical therapy, patients will have a stretching device (Dynasplint) used in rehabilitation to regain ROM in stiff joints. Patients will use this device 20-30 minutes 2 times per day at home.
Device: Dynasplint
Dynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or "Experimental" group will add this therapy to their standard of care regimen

Detailed Description:
The purpose of this study is to examine the effects of two treatment regimens for adhesive capsulitis: dynamic splinting and/or manual physical therapy.

Ages Eligible for Study:   40 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of idiopathic adhesive capsulitis
  • greater than 50% limitation in active flexion, internal rotation, or external rotation
  • Tight GHJ capsule in at least 2 directions
  • Capsular end-feel primarily limits ROM
  • Age 40- 64
  • Normal X-Rays

Exclusion Criteria:

  • Acute adhesive capsulitis
  • History of Diabetes Mellitus
  • Evidence of a cuff tear
  • Recent history of trauma
  • Evidence of glenohumeral DJD
  • History of shoulder surgery
  • Calcification of tendonitis demonstrated on a current X-Ray
  • Abnormal X-Ray
  • Cervical Radiculopathy/brachial plexus lesions
  • Less than 2+/5 muscle strength during mid-line manual muscle testing
  • Muscle Atrophy
  • Presence of associated systematic conditions
  • History of prior therapy for current condition
  • Manipulation under anesthesia
  • Non compliance
  • Shoulder-Hand syndrome, Complex Regional Pain Syndrome
  • History of prior injections for the current problem
  • Patient receiving worker's compensation
  • Shoulder symptoms with cervical provocative testing
  • Positive X-ray findings in the acromioclavicular or sternoclavicular joints
  • Abnormal physical signs or symptoms in the A-C or S-C joint
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00873158

United States, California
Gaspar Physical Therapy
Solana Beach, California, United States, 92075
United States, Florida
Andrews Research & Education Institute
Gulf Breeze, Florida, United States, 32561
United States, Pennsylvania
University Orthopedics Center
State College, Pennsylvania, United States, 16801
Sponsors and Collaborators
Dynasplint Systems, Inc.
McMurry University
Study Director: Buck Willis, PhD Dynasplint Systems, Inc.
  More Information


Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier: NCT00873158     History of Changes
Other Study ID Numbers: Shoulder 100 
Study First Received: March 31, 2009
Last Updated: August 8, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Dynasplint Systems, Inc.:
Adhesive Capsulitis

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on April 27, 2016